Creating technology to measure molecular composition from a distance
Official title: Developing Technology to Remotely Measure Molecular Composition
Funded at Mstm, LLC · NIH-10921741 · Data updated 2026-11-12
This study is working on a new technology that helps quickly and easily check surfaces for germs and harmful materials, making it easier for everyone to spot health risks like COVID-19 without needing special training.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mstm, LLC NIH-funded |
| Lab location | 1 site (Newark, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $258,586 |
| NIH project number | 1R43GM155491-01 |
| Project ID | NIH-10921741 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals at risk of exposure to infectious diseases or those in environments where hazardous materials may be present.
✕Less likely to help
Patients who are not at risk of infectious diseases or hazardous material exposure may not benefit from this research.
What this research studies
This research focuses on developing advanced technology for the remote detection of molecular composition, particularly for identifying infectious diseases and hazardous materials. By utilizing mass spectrometry, the project aims to create a system that can analyze surfaces for various pathogens and health-related issues without requiring extensive user expertise. The goal is to enable safe and accurate early-stage detection, which is crucial in managing public health threats like COVID-19 and other infectious diseases. This innovative approach seeks to minimize user intervention and maintenance, making it more accessible for widespread healthcare applications.
Why it matters
Potential benefit: If successful, this research could lead to improved early detection of infectious diseases and hazardous materials, enhancing public health safety.
How similar studies have gone: Other research has shown promise in using mass spectrometry for disease detection, indicating that this approach could be a significant advancement in the field.
Where this research is happening
-
Mstm, LLC
Newark, United States Active
Researchers
- Principal investigator: Trimpin, Sarah — Mstm, LLC
- Study coordinator: Trimpin, Sarah
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.